Close
ACHEMA MIDDLE EAST 2026
17TH Global Drug Delivery & Formulation Summit 2026

News

      NVIDIA and Lilly AI Lab All Set to Transform Drug Discovery

      Facilities & Operation
      NVIDIA and Eli Lilly and Company have announced the creation of a new NVIDIA-Lilly AI lab, designed to apply artificial intelligence to some of...

      Abalone and Pfizer Partner on Rare Activating Antibodies

      Drug Development
      Abalone Bio, which is a therapeutics biotech company that distinctively measures and also makes utmost use of large-scale activity datasets in order to discover...

      Samsung Bioepis Starts Direct Commercialization of Byooviz

      Europe
      Samsung Bioepis has begun its direct commercialization of Byooviz, which is a biosimilar to Genentech’s Lucentis - ranibizumab in Europe. The company has gone ahead...

      Daiichi Sankyo Plans to Boost Its Antibody-Drug Conjugate

      Facilities & Operation
      Daiichi Sankyo has recently made an announcement of its plans to invest almost 300 billion yen, which is equivalent to $1.9 billion, when it...

      Hengrui Pharma Inks 20-Year Licensing Agreement with Hansoh

      Asia
      Jiangsu Hengrui Pharmaceuticals, which is a China-based pharmaceutical company that is focused on research, development, and manufacturing, as well as the commercialization of innovative medicines, has gone...

      U.S. FDA Approves Weight Loss Pill from Novo Nordisk

      Drug Development
      The U.S. Food and Drug Administration approves a weight loss pill from Novo Nordisk, therefore giving the Danish drugmaker an edge in the race...

      U.S. FDA Approves Bispecific Lunsumio VELO™ by Roche

      Clinical Trials
      Roche has made an announcement that the US Food and Drug Administration (FDA) has provided approval for CD20xCD3 bispecific Lunsumio VELO™-mosunetuzumab as a subcutaneous...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.